Blog

Whitepaper: Considerations in support of achieving successful double blinding and removing bias with over encapsulation

About us | Advertise with us | Contact us

Posted: 11 September 2020 | Capsugel® | Lonza | No comments yet Automat Bath Bomb Machine

Whitepaper: Considerations in support of achieving successful double blinding and removing bias with over encapsulation

This whitepaper explores critical factors for over-encapsulation success. DBcaps® capsules offer a convenient option for blinding in clinical trials.

Over-encapsulation is a powerful tool which will be widely used throughout clinical trials for years to come. Patient-centric efforts of manufacturers and trial sponsors have forged a path for innovative products such as DBcaps®, to ensure the integrity of their study and avoid bias. Consideration must be given to the capsule’s compatibility with encapsulated products – dissolution, diffusion and stability studies are essential elements of selection. HPMC capsules offer a range of development benefits that complement traditional hard-gelatin capsules. This increases accessibility for sponsors and gives them greater flexibility and product compatibility when selecting their dosage format. We understand and control every step of over-encapsulation—from material selection to manufacture—and will leverage a simple, efficient means to flexibility and success in your double blinded clinical trials.

To read this whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.

This content is provided to you for free thanks to the kind support of our sponsor: Lonza

I am happy for my details to be shared with the sponsor(s) of this content *—Please choose an option—YesNo

Biopharmaceuticals, Drug Delivery Systems, Formulation, Research & Development (R&D)

Biopharmaceuticals, Drug Delivery Systems, Formulation, Research & Development (R&D)

All subscriptions include online membership, giving you access to the journal and exclusive content.

By Catherine Eckford (European Pharmaceutical Review)

By Catherine Eckford (European Pharmaceutical Review)

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Write for us | Advertise with us

European Pharmaceutical Review is published by: Russell Publishing Ltd. Court Lodge Hogtrough Hill Brasted, Kent, TN16 1NU United Kingdom

© Russell Publishing Limited, 2010-2023. All rights reserved.

Website development by e-Motive Media Limited.

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Whitepaper: Considerations in support of achieving successful double blinding and removing bias with over encapsulation

Bath Bomb Fizzi Press Machine CookieDescriptioncookielawinfo-checkbox-advertising-targetingThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".cookielawinfo-checkbox-analyticsThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".cookielawinfo-checkbox-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-performanceThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".PHPSESSIDThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.viewed_cookie_policyThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.zmember_loggedThis session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.